Prevalence of Chlamydia pneumoniae in Japanese rural districts: Association of smoking and physical activity with Chlamydia pneumoniae seropositivity

Internal Medicine

Volumn 42, Issue 10, 2003, Pages 960-966

  Mizooka, Masafumi ^a,b   Ishikawa, Shizukiyo ^a   Tsutsumi, Akizumi ^c   Hashimoto, Atsushi ^d   Kajii, Eiji ^a   Miyamoto, Hideki ^x   Akiyoshi, Hidetaka ^e   Yanagawa, Hiroshi ^f   Matsuo, Hitoshi ^g   Hiraoka, Jun ^h   Tsutsumi, Kaname ⁱ   Kayaba, Kazunori ^a   Kario, Kazuomi ^a   Shimada, Kazuyuki ^a   Sakai, Kenichiro ^j   Tsuruta, Kishio ^k   Sawada, Machi ^l   Furuse, Makoto ^a   Yoshimura, Manabu ^m   Hosoe, Masahiko ⁿ   Nago, Naoki ^o   Kodama, Nobuya ^p   Hayashishida, Noriko ^h   Yamaoka, Rika ^q   Yamada, Seishi ^r   Hayasaka, Shinya ^a   Takuma, Shuzo ^j   Goto, Tadao ^r   Natsume, Takafumi ^s   Yamada, Takashi ^t   Miyamoto, Takeshi ^x   Deguchi, Tomohiro ^j   Saegusa, Tomohiro ^u   Shibano, Yoshihiro ^v   Ito, Yoshihisa ^w   Nakamura, Toshikazu ^a   more..

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Aichi Prefectural Owari Hospital   (Japan)

^e FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f SAITAMA PREFECTURAL UNIVERSITY   (Japan)

^g GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^h Tako Chuo Hospital   (Japan)

ⁱ Kyushu International University   (Japan)

^j Akaike Town Hospital   (Japan)

^k Takasu Natl Health Insurance Clinic   (Japan)

^l Agawa Osaki National Health Insurance Clinic   (Japan)

^m Medical School   (Japan)

ⁿ Division of Orthopaedic Surgery   (Japan)

^o Tsukude National Health Ins Clinic   (Japan)

^p Sakugi Clinic   (Japan)

^q Awaji Hokudan Public Clinic   (Japan)

^r Wara National Health Insurance Hospital   (Japan)

^s Oyama Municipal Hospital   (Japan)

^t Kuze Clinic   (Japan)

^u Sakuma Natl Hlth Insurance Hosp   (Japan)

^v Saiseikai Iwaizumi Hospital   (Japan)

^w ASAHIKAWA MEDICAL COLLEGE   (Japan)

^x NONE

more..

Author keywords

Chlamydia pneumoniae; Physical activity; Seropositivity; Smoking

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; BODY MASS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; JAPAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; PHYSICAL ACTIVITY; PHYSIOLOGY; PREVALENCE; RISK FACTOR; RURAL AREA; RURAL POPULATION; SEROLOGY; SEROPREVALENCE; SMOKING;

EID: 10744222497     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.960     Document Type: Article

References (39)

1. Grayston JT, Wang SP, Kuo CC, Campbell LA. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis 8: 191-202, 1989.
2. Kuo CC, Jackson LA, Campbell L, Grayston JT. Chlamydia pneumoniae. Clin Microbiol Rev 8: 451-461, 1995.
3. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33: 492-503, 2001.
4. Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumoniae and atherosclerosis. Heart 81: 232-238, 1999.
5. Gupta S. Chronic infection in the aetiology of atherosclerosis-focus on Chlamydia pneumoniae. Atherosclerosis 143: 1-6, 1999.
6. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116: 273-278, 1992.
7. Karvonen M, Tuomilehto J, Pitkaniemi J, Naukakarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 23: 1315-1321, 1994.
8. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Chlamydia pneumoniae and Helicobacter pylori infections in Sami and Finnish reindeer herders. Int Circumpolar Health 56: 70-75, 1997.
9. Ferrari M, Poli A, Olivieri M, et al. Seroprevalence of Chlamydia pneumoniae antibodies in a young adult population sample living in Verona. Infection 28: 38-41, 2000.
10. Mendall M, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 30: 121-128, 1995.
11. O'Neill C, Murray LJ, Ong GM, et al. Epidemiology of Chlamydia pneumoniae infection in a randomly selected population in a developed country. Epidemiol Infect 122: 111-116, 1999.
12. Koivisto AL, Isoaho R, Von Hertzen L, et al. Chlamydia antibodies in an elderly Finnish population. Scand J Infect Dis 31: 135-139, 1999.
13. Paltiel O, Kark JD, Leionen M, Saikku P. High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol Infect 114: 465-473, 1995.
14. DaDesh J, Wong Y, Ward M, Muir J. Risk factors for coronary heart disease and persistent infection with Chlamydia pneumoniae or cytomegalovirus: a population-based study. J Cardiovasc Risk 6: 387-390, 1999.
15. Murray LJ, O'Reilly DP, Ong GM, O'Neill C, Evans AE, Bamford KB. Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile. Heart 81: 239-244, 1999.
16. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study. BMJ 314: 1456-1457, 1997.
17. Coles KA, Plant AJ, Riley TV, Smith DW, McQuillan BM, Thompson PL. Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. Am J Cardiol 84: 825-828, 1999.
18. Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 100: 832-837, 1999.
19. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vase Biol 17: 2910-2913, 1997.
20. Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 321: 208-213, 2000.
21. Kishimoto T. Studies on Chlamydia pneumoniae strain TWAR. Infection. Kansenshogaku Zasshi 64: 986-993, 1990 (Abstract in English).
22. Ouchi K, Kanamoto Y, Ushio M. Prevalence of antibodies to Chlamydia pneumoniae (strain TWAR) and other Chlamydia in Japan. Kansenshogaku Zasshi 65: 19-25, 1991 (Abstract in English).
23. Numazaki K, Ikebe T, Chiba S. Detection of serum antibodies against Chlamydia pneumoniae by ELISA. FEMS Immunol Med Microbiol 14: 179-183, 1996.
24. Kosaka C, Hara K, Komiyama Y, Takahashi H. Possible role of chronic infection with Chlamydia pneumoniae in Japanese patients with acute myocardial infarction. Jpn Circ J 64: 819-824, 2000.
25. Maeda N, Sawayama Y, Tatsukawa M, Shimizu C, Kashiwagi S, Hayashi J. Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population. Atherosclerosis 164: 313-319, 2002.
26. Hahn D, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae. Arterioscler Thromb 12: 945-947, 1992.
27. Von Hertzen L, Surcel HM, Kaprio J, et al. Immune response to Chlamydia pneumoniae in twins in relation to gender and smoking. J Med Microbiol 47: 441-446, 1998.
28. Von Hertzen L, Kaprio J, Koskenvuo M, Isoaho R, Saikku P. Humoral immune response to Chlamydia pneumoniae in twins discordant for smoking. J Inter Med 244: 227-234, 1998.
29. Blake GH, Abell TD, Stanley WG. Cigarette smoking and upper respiratory infection among recruits in basic combat training. Ann Intern Med 109: 198-202, 1988.
30. Sherman CB. Health effects of cigarette smoking. Clin Chest Med 12: 643-658, 1991.
31. Nago N, Kayaba K, Hiraoka J, et al. Lipoprotem(a) levels in the Japanese population: Influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study. Am J Epidemiol 141: 815-821, 1995.
32. Kayaba K, Nago N, Miyamoto T, et al. Glycated hemoglobin levels and their correlation with atherosclerotic risk factors in a Japanese population - The Jichi Medical School Cohort Study 1993-1995. Jpn Circ J 62: 261-266, 1998.
33. Ishikawa S, Kario K, Nago N, et al. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study. Thromb Haemost 77: 890-893, 1997.
34. Tsutsumi A, Tsutsumi K, Kayaba K, Igarashi M. Health-related behaviors, social support, and community morale. International Journal of Behavioral Medicine 5: 166-182, 1998.
35. Ishikawa S, Gotoh T, Nago N, Kayaba K. The Jichi Medical School (JMS) Cohort Study: design, baseline data and standardized mortality ratios. J Epidemiol 12: 408-417, 2002.
36. Kannel WB, Sorlie P. Some health benefits of physical activity. The Framingham Study. Arch Intern Med 139: 857-861, 1979.
37. Kishimoto T, Kubota Y, Matsushima T, et al. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method 1. Evaluation of ELISA kit using outer membrane complex. Kansenshogaku Zasshi 70: 821-829, 1996 (Abstract in English).
38. Kishimoto T, Kubota Y, Matsushima T, et al. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards. Kansenshogaku Zasshi 70: 830-839, 1996 (Abstract in English).
39. Kishimoto T, Matsushima T, Morikawa T, Kawagoe K. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method 3. setting of serological criteria. Kansenshogaku Zasshi 73: 457-466, 1999 (Abstract in English).